GSM7909557: human_D_Galactosamine_72_0.3_mM_C09; Homo sapiens; RNA-Seq
Following treatment with HFPO-DA or positive controls (i.e., GW7647, rosiglitazone, acetaminophen or d-galactosamine) for 12, 24 or 72 h, hepatocytes were lysed using TempO-Seq® Enhanced Lysis Buffer and processed according to the TempO-Seq® protocol by BioSypder Technologies. TempO-Seq® protocol by BioSypder Technologies